Company profile
Scopio Labs , Ltd.
Scopio Labs , Ltd. has 3 AI-enabled medical devices on the FDA list. The first decision was on October 2, 2020 and the most recent on June 27, 2025 (X100/X100HT with Full Field Peripheral Blood Smear (PBS) Application). Its most common review panel is Hematology (3 devices).
3AI devices
2020First decision
2025Latest decision
1Specialties
Per year
202020222025
By specialty
Related guides
Timeline
- X100/X100HT with Full Field Peripheral Blood Smear (PBS) Application · Hematology · JOY
- X100HT with Slide Loader with Full Field Peripheral Blood Smear (PBS) Application · Hematology · JOY
- X100 with Full Field Peripheral Blood Smear (PBS) Application · Hematology · JOY